M. Nagaki and H. Moriwaki, Transcription factor HNF and hepatocyte differentiation, Hepatol Res, vol.38, pp.961-969, 2008.

C. Guguen-guillouzo and A. Guillouzo, General review on in vitro hepatocyte models and their applications, Methods Mol. Biol, vol.640, pp.1-40, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00742202

P. Godoy, A. Widera, W. Schmidt-heck, G. Campos, C. Meyer et al., Gene network activity in cultivated primary hepatocytes is highly similar to diseased mammalian liver tissue, Arch. Toxicol, vol.90, pp.2513-2529, 2016.

A. Vildhede, J. R. Wisniewski, A. Noren, M. Karlgren, and P. Artursson, Comparative Proteomic Analysis of Human Liver Tissue and Isolated Hepatocytes with a Focus on Proteins Determining Drug Exposure, J. Proteome Res, vol.14, pp.3305-3314, 2015.

J. R. Wisniewski, A. Vildhede, A. Noren, and P. Artursson, In-depth quantitative analysis and comparison of the human hepatocyte and hepatoma cell line HepG2 proteomes, J. Proteom, vol.136, pp.234-247, 2016.

R. Gebhardt and M. Matz-soja, Liver zonation: Novel aspects of its regulation and its impact on homeostasis, World J. Gastroenterol, vol.20, pp.8491-8504, 2014.

A. Rogue, C. Lambert, C. Spire, N. Claude, and A. Guillouzo, Interindividual variability in gene expression profiles in human hepatocytes and comparison with HepaRG cells, Drug Metab. Dispos, vol.40, pp.151-158, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00865978

E. L. Lecluyse, Human hepatocyte culture systems for the in vitro evaluation of cytochrome P450 expression and regulation, Eur. J. Pharm. Sci, vol.13, pp.343-368, 2001.

T. B. Andersson, K. P. Kanebratt, and J. G. Kenna, The HepaRG cell line: A unique in vitro tool for understanding drug metabolism and toxicology in human, Expert Opin. Drug Metab. Toxicol, vol.8, pp.909-920, 2012.

V. Cerec, D. Glaise, D. Garnier, S. Morosan, B. Turlin et al., Transdifferentiation of hepatocyte-like cells from the human hepatoma HepaRG cell line through bipotent progenitor, Hepatology, vol.45, pp.957-967, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00690471

C. C. Bell, V. M. Lauschke, S. U. Vorrink, H. Palmgren, R. Duffin et al., Ingelman-Sundberg, M. Transcriptional, Functional, and Mechanistic Comparisons of Stem Cell-Derived Hepatocytes, HepaRG Cells, and Three-Dimensional Human Hepatocyte Spheroids as Predictive In Vitro Systems for Drug-Induced Liver Injury, vol.45, pp.419-429, 2017.

M. C. Smith, E. Timmins-schiffman, M. Coton, E. Coton, N. Hymery et al., Differential impacts of individual and combined exposures of deoxynivalenol and zearalenone on the HepaRG human hepatic cell proteome, J. Proteom, vol.173, pp.89-98, 2018.

P. Gripon, S. Rumin, S. Urban, J. Le-seyec, D. Glaise et al., Infection of a human hepatoma cell line by hepatitis B virus, Proc. Natl. Acad. Sci, vol.99, pp.15655-15660, 2002.

J. R. Wisniewski and D. Rakus, Multi-enzyme digestion FASP and the 'Total Protein Approach'-based absolute quantification of the Escherichia coli proteome, J. Proteom, vol.109, pp.322-331, 2014.

S. Klein, D. Mueller, V. Schevchenko, and F. Noor, Long-term maintenance of HepaRG cells in serum-free conditions and application in a repeated dose study, J. Appl. Toxicol, vol.34, pp.1078-1086, 2014.

M. I. Plumel, M. Benhaim-delarbre, M. Rompais, D. Thierse, G. Sorci et al., Differential proteomics reveals age-dependent liver oxidative costs of innate immune activation in mice, J. Proteom, vol.135, pp.181-190, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01298522

J. Cox, N. Neuhauser, A. Michalski, R. A. Scheltema, J. V. Olsen et al., Andromeda: A peptide search engine integrated into the MaxQuant environment, J Proteome Res, vol.10, pp.1794-1805, 2011.

. Uniprot, , p.7, 2016.

C. Carapito, A. Burel, P. Guterl, A. Walter, F. Varrier et al., Van Dorsselaer, A. MSDA, a proteomics software suite for in-depth Mass Spectrometry Data Analysis using grid computing, Proteomics, vol.14, pp.1014-1019, 2014.

J. A. Vizcaino, A. Csordas, N. Del-toro, J. A. Dianes, J. Griss et al., update of the PRIDE database and its related tools, Nucleic Acids Res, vol.44, pp.447-456, 2016.

. R-core-team, R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, p.15, 2017.

A. Chawade, E. Alexandersson, and F. Levander, Normalyzer: A tool for rapid evaluation of normalization methods for omics data sets, J Proteome Res, vol.13, pp.3114-3120, 2014.

J. R. Wisniewski, M. Y. Hein, J. Cox, and M. Mann, A "proteomic ruler" for protein copy number and concentration estimation without spike-in standards, Mol. Cell. Proteom, vol.13, pp.3497-3506, 2014.

A. W. Duncan, Aneuploidy, polyploidy and ploidy reversal in the liver, Semin. Cell Dev. Biol, vol.24, pp.347-356, 2013.

, KEGG: Kyoto Encyclopedia of Genes and Genomes, p.30, 2018.

, SignalP-4.1 Server. Available online, p.15, 2016.

C. A. Schneider, W. S. Rasband, K. W. Eliceiri, and . Nih, Image to ImageJ: 25 years of image analysis, Nat Methods, vol.9, pp.671-675, 2012.

J. Cox and M. Mann, 1D and 2D annotation enrichment: A statistical method integrating quantitative proteomics with complementary high-throughput data, BMC Bioinform, vol.2012

T. V. Pham, S. R. Piersma, M. Warmoes, and C. R. Jimenez, On the beta-binomial model for analysis of spectral count data in label-free tandem mass spectrometry-based proteomics, Bioinformatics, vol.26, pp.363-369, 2010.

J. P. Jackson, L. Li, E. D. Chamberlain, H. Wang, and S. S. Ferguson, Contextualizing Hepatocyte Functionality of Cryopreserved HepaRG Cell Cultures, Drug Metab. Dispos, vol.44, pp.1463-1479, 2016.

B. B. Knowles, C. C. Howe, and D. P. Aden, Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen, Science, vol.209, pp.497-499, 1980.

D. Lopez-terrada, S. W. Cheung, M. J. Finegold, and B. B. Knowles, Hep G2 is a hepatoblastoma-derived cell line, Hum. Pathol, vol.40, pp.1512-1515, 2009.

R. Milo, What is the total number of protein molecules per cell volume? A call to rethink some published values, Bioessays, vol.35, pp.1050-1055, 2013.

P. Gissen and I. M. Arias, Structural and functional hepatocyte polarity and liver disease, J. Hepatol, vol.63, pp.1023-1037, 2015.

A. Sharanek, A. Burban, M. Burbank, R. Le-guevel, R. Li et al., Rho-kinase/myosin light chain kinase pathway plays a key role in the impairment of bile canaliculi dynamics induced by cholestatic drugs, Sci. Rep, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01326368

H. W. Yang, M. G. Shin, S. Lee, J. R. Kim, W. S. Park et al., Cooperative activation of PI3K by Ras and Rho family small GTPases, Mol. Cell, vol.47, pp.281-290, 2012.

A. Thenappan, Y. Li, K. Kitisin, A. Rashid, K. Shetty et al., Role of transforming growth factor beta signaling and expansion of progenitor cells in regenerating liver, Hepatology, vol.51, pp.1373-1382, 2010.

L. Guillemot, Y. Schneider, P. Brun, I. Castagliuolo, D. Pizzuti et al., Cingulin is dispensable for epithelial barrier function and tight junction structure, and plays a role in the control of claudin-2 expression and response to duodenal mucosa injury, J. Cell Sci, vol.125, pp.5005-5014, 2012.

J. O. Russel and S. P. Monga, Wnt/?-catenin signaling in liver development, homeostasis, and pathobiology, Annu. Rev. Pathol. Mech. Dis, vol.13, pp.351-378, 2018.

D. Lopez-terrada, P. H. Gunaratne, A. M. Adesina, J. Pulliam, D. M. Hoang et al., Histologic subtypes of hepatoblastoma are characterized by differential canonical Wnt and Notch pathway activation in DLK+ precursors, Hum. Pathol, vol.40, pp.783-794, 2009.

C. Torre, C. Perret, and S. Colnot, Transcription dynamics in a physiological process: Beta-catenin signaling directs liver metabolic zonation, Int. J. Biochem. Cell Biol, vol.43, pp.271-278, 2011.

R. Hoekstra, G. A. Nibourg, T. V. Van-der-hoeven, M. T. Ackermans, T. B. Hakvoort et al., The HepaRG cell line is suitable for bioartificial liver application, Int. J. Biochem. Cell Biol, vol.43, pp.1483-1489, 2011.

M. F. Moedas, A. A. Adam, M. A. Farelo, L. Ijlst, R. A. Chalumeau et al., Advances in methods for characterization of hepatic urea cycle enzymatic activity in HepaRG cells using UPLC-MS/MS, Anal. Biochem, vol.535, pp.47-55, 2017.

K. Pernelle, R. Le-guevel, D. Glaise, C. G. Stasio, T. Le-charpentier et al., Automated detection of hepatotoxic compounds in human hepatocytes using HepaRG cells and image-based analysis of mitochondrial dysfunction with JC-1 dye, Toxicol. Appl. Pharm, vol.254, pp.256-266, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00740177

C. Xu, C. Y. Li, and A. N. Kong, Induction of phase I, II and III drug metabolism/transport by xenobiotics, Arch. Pharm. Res, vol.28, pp.249-268, 2005.

C. Aninat, A. Piton, D. Glaise, T. Le-charpentier, S. Langouet et al., Expression of cytochromes P450, conjugating enzymes and nuclear receptors in human hepatoma HepaRG cells, Drug Metab. Dispos, vol.34, pp.75-83, 2006.
URL : https://hal.archives-ouvertes.fr/hal-00702085

L. Wigger, C. Casals-casas, M. Baruchet, K. Trang, S. Pradervand et al., System analysis of the functional cross-talk between PPARalpha, LXR and FXR in the human HepaRG liver cells

K. P. Kanebratt and T. B. Andersson, Evaluation of HepaRG cells as an in vitro model for human drug metabolism studies, Drug Metab. Dispos, vol.36, pp.1444-1452, 2008.

E. A. Attignon, A. F. Leblanc, B. Le-grand, C. Duval, M. Aggerbeck et al., Novel roles for AhR and ARNT in the regulation of alcohol dehydrogenases in human hepatic cells, Arch. Toxicol, vol.91, pp.313-324, 2017.

E. H. Sarsour, A. L. Kalen, and P. C. Goswami, Manganese superoxide dismutase regulates a redox cycle within the cell cycle, Antioxid. Redox Signal, vol.20, pp.1618-1627, 2014.

M. Hu, Y. Zou, S. M. Nambiar, J. Lee, Y. Yang et al., Keap1 modulates the redox cycle and hepatocyte cell cycle in regenerating liver, Cell Cycle, vol.13, pp.2349-2358, 2014.

D. Gilot, P. Loyer, A. Corlu, D. Glaise, D. Lagadic-gossmann et al., Liver protection from apoptosis requires both blockage of initiator caspase activities and inhibition of ASK1/JNK pathway via glutathione S-transferase regulation, J. Biol. Chem, vol.277, pp.49220-49229, 2002.

A. Burban, A. Sharanek, R. Hue, M. Gay, S. Routier et al., Penicillinase-resistant antibiotics induce non-immune-mediated cholestasis through HSP27 activation associated with PKC/P38 and PI3K/AKT signaling pathways
URL : https://hal.archives-ouvertes.fr/inserm-01522586

S. Madec, V. Cerec, E. Plee-gautier, J. Antoun, D. Glaise et al., CYP4F3B expression is associated with differentiation of HepaRG human hepatocytes and unaffected by fatty acid overload, Drug Metab. Dispos, vol.39, 1987.
URL : https://hal.archives-ouvertes.fr/hal-00739991

C. H. Samanez, S. Caron, O. Briand, H. Dehondt, I. Duplan et al., The human hepatocyte cell lines IHH and HepaRG: Models to study glucose, lipid and lipoprotein metabolism, Arch. Physiol. Biochem, vol.118, pp.102-111, 2012.

B. S. Hijmans, A. Grefhorst, M. H. Oosterveer, and A. K. Groen, Zonation of glucose and fatty acid metabolism in the liver: Mechanism and metabolic consequences, Biochimie, vol.96, pp.121-129, 2014.

J. A. Hall, M. Tabata, J. T. Rodgers, and P. Puigserver, USP7 attenuates hepatic gluconeogenesis through modulation of FoxO1 gene promoter occupancy, Mol. Endocrinol, vol.28, pp.912-924, 2014.

M. Adachi, Y. Osawa, H. Uchinami, T. Kitamura, D. Accili et al., The forkhead transcription factor FoxO1 regulates proliferation and transdifferentiation of hepatic stellate cells, Gastroenterology, vol.132, pp.1434-1446, 2007.

R. Parent, D. Kolippakkam, G. Booth, and L. Beretta, Mammalian target of rapamycin activation impairs hepatocytic differentiation and targets genes moderating lipid homeostasis and hepatocellular growth, Cancer Res, vol.67, pp.4337-4345, 2007.

P. Agrawal, J. Reynolds, S. Chew, D. A. Lamba, and R. E. Hughes, DEPTOR is a stemness factor that regulates pluripotency of embryonic stem cells, J. Biol. Chem, vol.289, pp.31818-31826, 2014.

N. Stefan and H. U. Haring, The role of hepatokines in metabolism, Nat. Rev. Endocrinol, vol.9, pp.144-152, 2013.

H. Y. Ou, H. T. Wu, H. C. Hung, Y. C. Yang, J. S. Wu et al., Endoplasmic reticulum stress induces the expression of fetuin-A to develop insulin resistance, Endocrinology, vol.153, pp.2974-2984, 2012.

M. Wagner and M. Trauner, Recent advances in understanding and managing cholestasis, vol.5, 2016.

H. Tilg, A. R. Moschen, and M. Roden, Nat. Rev. Gastroenterol. Hepatol, vol.14, pp.32-42, 2017.

H. Yang, K. Ko, M. Xia, T. W. Li, P. Oh et al., Induction of avian musculoaponeurotic fibrosarcoma proteins by toxic bile acid inhibits expression of glutathione synthetic enzymes and contributes to cholestatic liver injury in mice, Hepatology, vol.51, pp.1291-1301, 2010.

A. Sharanek, P. B. Azzi, H. Al-attrache, C. C. Savary, L. Humbert et al., Different dose-dependent mechanisms are involved in early cyclosporine a-induced cholestatic effects in hepaRG cells, Toxicol. Sci, vol.141, pp.244-253, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01016342

K. Dessalle, V. Euthine, S. Chanon, J. Delarichaudy, I. Fujii et al., SREBP-1 transcription factors regulate skeletal muscle cell size by controlling protein synthesis through myogenic regulatory factors, PLoS One, vol.7, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-00809752